Phase I Study of Lenalidomide in Patients With Acute Leukemia

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by University of California, Davis
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
University of California, Davis
ClinicalTrials.gov Identifier:
NCT01615042
First received: June 6, 2012
Last updated: February 28, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)